Lutetium Lu-177 dotatate
This is a radioactive medication used to treat certain types of neuroendocrine tumors. It works by delivering targeted radiation to cancer cells that have specific receptors on their surface. The medication attaches to these receptors and delivers radiation directly to the tumor cells, helping to destroy them while minimizing damage to healthy tissue.

Octreotide LAR
This is a long-acting medication that helps control symptoms caused by neuroendocrine tumors. It works by reducing the production of certain hormones that can cause symptoms like diarrhea and flushing. It also helps slow down tumor growth by blocking signals that cancer cells use to multiply.

Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) – A rare type of cancer that develops in the neuroendocrine cells of the digestive system and pancreas. These tumors can form in any part of the gastrointestinal tract or pancreas, where they grow from specialized cells that produce hormones. GEP-NETs typically grow slowly over several years, though their growth pattern can vary. The tumors can produce various hormones and other substances that may cause specific symptoms depending on the tumor’s location and type. These tumors can develop in different parts of the digestive system, including the stomach, small intestine, large intestine, rectum, and pancreas.